Table 3.

Lipid contents in the liver samples. (mean ± SD, n = 8).

	TC (mmol/L)	TG (mmol/L)	FFA (μmol/L)	LDL-C (mmol/L)	HDL-C (mmol/L)	AST (U/L)	ALT (U/L)
CON	0.75 ± 0.13∗∗∗	1.13 ± 0.17∗∗∗	230.99 ± 22.83∗∗	1.39 ± 0.11∗∗∗	1.47 ± 0.16∗∗	2199.29 ± 114.52∗∗∗	1550.52 ± 157.42∗∗∗
MOD	1.59 ± 0.04	1.64 ± 0.11	440.22 ± 31.54	2.46 ± 0.32	1.07 ± 0.27	2856.18 ± 145.88	22242.08 ± 154.16
EZE	1.05 ± 0.14∗∗∗	1.31 ± 0.19∗∗∗	263.32 ± 21.83∗∗	1.49 ± 0.22∗∗∗	1.37 ± 0.28∗	2401.43 ± 99.03∗∗	1723.72 ± 182.66∗∗∗
WEAV.L	1.18 ± 0.19∗∗	1.45 ± 0.2	302.29 ± 33.41∗	1.69 ± 0.52∗∗	1.01 ± 0.2	2607.46 ± 58.35	2040.9 ± 145.07∗
WEAV.M	1.28 ± 0.20∗∗	1.44 ± 0.2	297.78 ± 33.45∗∗	1.70 ± 0.52 ∗∗	1.06 ± 0.22	2590.23 ± 163.64∗	2042.8 ± 120.54∗∗
WEAV.H	1.15 ± 0.23∗∗	1.39 ± 0.14∗∗	276.34 ± 35.22∗∗	1.90 ± 0.34 ∗∗	1.19 ± 0.35	2520.18 ± 140.79∗	1756.52 ± 118.37∗∗∗
VOAV.L	1.15 ± 0.14∗∗	1.46 ± 0.15∗∗	283.87 ± 21.89∗∗	1.57 ± 0.48∗∗∗	1.41 ± 0.35∗	2458.48 ± 110.67∗∗	1849.07 ± 131.94∗∗∗
VOAV.M	1.14 ± 0.21∗∗	1.35 ± 0.17∗∗∗	289.06 ± 26.28∗∗	1.46 ± 0.17∗∗∗	1.33 ± 0.31∗	2457.13 ± 182.37∗∗	1762.82 ± 116.12∗∗∗
VOAV.H	1.15 ± 0.18∗∗	1.421 ± 0.14∗∗∗	222.63 ± 22.24∗∗	1.38 ± 0.21∗∗∗	1.39 ± 0.27∗	2255.16 ± 78.83∗∗∗	1868.12 ± 200.21∗∗∗
BA.L	1.25 ± 0.18∗∗	1.37 ± 0.2∗∗	277.99 ± 22.44∗∗	1.83 ± 0.41∗∗	1.48 ± 0.42∗	2616.1 ± 153.52∗	1858.3 ± 131.9∗∗∗
BA.M	1.15 ± 0.23∗∗	1.46 ± 0.09∗∗	270.67 ± 26.81∗∗	1.69 ± 0.51∗∗	1.31 ± 0.36	2455.19 ± 91.44∗∗	1848.72 ± 156.98∗∗∗
BA.H	1.17 ± 0.14∗∗	1.32 ± 0.14∗∗∗	268.17 ± 33.29∗∗	1.67 ± 0.34∗∗∗	1.32 ± 0.17∗	2331.97 ± 167.89∗∗∗	1803.57 ± 129.19∗∗∗

∗indicates a significant difference compared with model group; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.